Assessing patient‐reported symptom burden of long‐term head and neck cancer survivors at annual surveillance in survivorship clinic

This study reports long‐term head and neck cancer (HNC) patient‐reported symptoms using the MD Anderson Symptom Inventory Head and Neck Cancer Module (MDASI‐HN) in a large cohort of HNC survivors.

[1]  C. Fuller,et al.  Single‐item discrimination of quality‐of‐life–altering dysphagia among 714 long‐term oropharyngeal cancer survivors: Comparison of patient‐reported outcome measures of swallowing , 2019, Cancer.

[2]  K. Armeson,et al.  Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads , 2019, Journal of Cancer Survivorship.

[3]  Mona Kamal,et al.  Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  J. Ringash,et al.  Head and Neck Cancer Survivorship Care: A Review of the Current Guidelines and Remaining Unmet Needs , 2018, Current Treatment Options in Oncology.

[5]  J. Soria,et al.  Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers? , 2018, European Journal of Cancer.

[6]  Aubrey L. White,et al.  Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  C. Fuller,et al.  Symptom burden as a driver of decisional regret in long‐term oropharyngeal carcinoma survivors , 2017, Head & neck.

[8]  J. Pignon,et al.  Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Jeremy M. Aymard,et al.  Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old , 2017, Radiation Oncology.

[10]  Barbara Ebersole,et al.  Maximizing Functional Outcomes in Head and Neck Cancer Survivors: Assessment and Rehabilitation. , 2017, Otolaryngologic clinics of North America.

[11]  A. Garden,et al.  Predicting two‐year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma , 2017, The Laryngoscope.

[12]  L. Siu,et al.  Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Wess A. Cohen,et al.  Health-Related Quality of Life following Reconstruction for Common Head and Neck Surgical Defects , 2016, Plastic and reconstructive surgery.

[14]  R. Volk,et al.  Assessing head and neck cancer patient preferences and expectations: A systematic review. , 2016, Oral oncology.

[15]  J. Waldron,et al.  Prevalence and nature of survivorship needs in patients with head and neck cancer , 2016, Head & neck.

[16]  S. J. LaMonte,et al.  American Cancer Society Head and Neck Cancer Survivorship Care Guideline , 2016, CA: a cancer journal for clinicians.

[17]  J. Tepper,et al.  Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. , 2015, International journal of radiation oncology, biology, physics.

[18]  J. Ringash,et al.  Survivorship and Quality of Life in Head and Neck Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Rogers,et al.  What patients consider important: temporal variations by early and late stage oral, oropharyngeal and laryngeal subsites. , 2014, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[20]  D. Eisele,et al.  The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. , 2014, Oral oncology.

[21]  E. Ward,et al.  Survivors' experiences of dysphagia-related services following head and neck cancer: implications for clinical practice. , 2014, International journal of language & communication disorders.

[22]  F. Feng,et al.  Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. , 2013, International journal of radiation oncology, biology, physics.

[23]  K. Ang,et al.  Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Lewin,et al.  Functional Outcomes after Chemoradiotherapy of Laryngeal and Pharyngeal Cancers , 2012, Current Oncology Reports.

[25]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  H. Brenner,et al.  Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. , 2010, The oncologist.

[27]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[28]  G. Funk,et al.  The role of pain in head and neck cancer recurrence and survivorship. , 2009, Archives of otolaryngology--head & neck surgery.

[29]  N. Aaronson,et al.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[31]  Tito R Mendoza,et al.  Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module , 2007, Head & neck.

[32]  C. Cleeland,et al.  Assessing symptom distress in cancer patients , 2000 .

[33]  C. Cleeland,et al.  The rapid assessment of fatigue severity in cancer patients , 1999, Cancer.

[34]  Katherine R. Edwards,et al.  When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function , 1995, Pain.

[35]  S. McEwen,et al.  Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs. , 2018, Seminars in radiation oncology.

[36]  C. Cleeland,et al.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. , 2000, Cancer.

[37]  S. Leff.  What is Cancer , 1970 .